Breathing Experts Lead New Pediatric Tracheostomy Guidelines

With an increase in tracheostomies among infants and children, Christopher Baker, MD, has led the American Thoracic Society effort to update its pediatric tracheostomy guidelines.

Ignoring Bilateral Conditions Can Bias Orthopedic Research Outcomes

In this simulated trial, our orthopedic experts show that failing to account for bilateral conditions in clinical studies can lead to inaccurate results that could misinform decision-making.

2026

Q&A: Understanding Risk-Taking Behaviors in Teens

Understand why kids engage in risky behaviors like vaping so you can help them make safe choices and explore risk in a way that supports their development.

The 70^th Peña Course: Continuing a Legacy

Alberto Peña, MD, and his team of colorectal, gynecologic and urologic surgeons host the 70th Colorectal Workshop, imparting decades of surgical experience.

Study Uncovers Gap in Care Transition for Young Adults with Kidney Disease

The transition period from pediatric to adult nephrology care is a critical time for young adults with kidney disease yet our study found most academic medical centers don’t offer structured support.

How Pelvic Radiation Impacts Lower Urinary Tract Function in Pediatric Cancer Survivors

See how this study identified childhood cancer survivors at an increased risk of late effects impacting lower urinary dysfunction after pelvic external beam radiation treatment.

New Program Ensures Safety and Quality in Novel Therapeutics and Precision Medicine

Our Center for Transformative Therapeutics is setting new standards for safety and quality in pediatric precision medicine.

Controlling Inflammation Improves Outcomes in Pediatric EoE

Histologic remission in pediatric EoE improves esophageal distensibility suggesting better outcomes, while FLIP technology can detect early narrowing to help predict the risk of future complications.

Discovery of New Genetic Variant Could Transform Hemophilia A Treatment

Researchers at the University of Colorado Anschutz Medical Campus and Children’s Hospital Colorado discovered a new factor VIII gene variant that could lead to safer, longer-lasting hemophilia A therapies.